Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Pituitary Disorders
Can combined oral contraceptive use cause falsely elevated 24-hour urine-free cortisol?
Answer from: at Community Practice
UFC is an expression of free cortisol. It should not be affected by oral estrogen.
Sign In
or
Register
to read more
Answer from: at Community Practice
Cushing is generally diagnosed by multiple tests so if one is abnormal, it is recommended to do other tests such as an overnight dexamethasone suppression test and saliva cortisol and put everything together to make the diagnosis.
Sign In
or
Register
to read more
20091
20071
Related Questions
In patients with confirmed hypercortisolism with a high/normal unsuppressed ACTH who have both a pituitary adenoma and adrenal adenoma identified on imaging, can you reliably use DHEA-S to determine the source of cortisol production?
In patients using NuvaRing for contraception, is the 1mg dexamethasone suppression test reliable to screen for cortisol excess?
What should the LDL target be in patients with prediabetes and high lipoprotein (a) with family history of coronary artery disease?
What is the recommended approach to treating severe constipation in patients on GLP1 R agonist therapy?
How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
Would you start once-weekly tirzepatide over once daily basal insulin in a patient with Type 2 diabetes with inadequate control on oral antihyperglycemia drugs?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
How should we approach the recommendation of intermittent fasting for weight loss in patients with pre-existing cardiovascular conditions, given the observed association of increased CV mortality with eating durations of less than 8 hrs?
Should we be more cautious with the use of GLP 1 R agonist therapy in patients with Type 1 diabetes mellitus and obesity given the increased risk of cardiovascular disease with high body weight variability?